Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer
Clinical trial NCT05775900 · COMPLETED
Trial details
- NCT number
- NCT05775900
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2025-07-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.